Affinity Investment Advisors’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-3,917	Closed	-$311K	–	204
2016 Q4	$311K	Hold	3,917	–	–	0.03%	135
2016 Q3	$274K	Buy	+3,917	New	+$274K	0.02%	132
2016 Q2	–	Sell	-5,167	Closed	-$209K	–	176
2016 Q1	$209K	Buy	+5,167	New	+$209K	0.02%	152